Journal article
Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial
KC Hsiao, AL Ponsonby, C Axelrad, S Pitkin, MLK Tang, W Burks, S Donath, F Orsini, D Tey, M Robinson, EL Su
Lancet Child and Adolescent Health | ELSEVIER SCI LTD | Published : 2017
Abstract
Background Oral immunotherapy has attracted much interest as a potential treatment for food allergy, yet little is known about its long-term effects. We aimed to assess long-term outcomes in participants who completed a randomised, double-blind, placebo-controlled trial of combined probiotic and peanut oral immunotherapy (PPOIT), which was previously shown to induce desensitisation and 2-week sustained unresponsiveness. Methods All participants who completed the PPOIT randomised trial were eligible to participate in this follow-up study 4 years after treatment cessation. Peanut intake and adverse reactions to peanut in the 4 years after treatment cessation were systematically documented with..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
Murdoch Childrens Research Institute and Australian Food Allergy Foundation.